These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 27099439
1. Norcantharidin combined with ABT-737 for hepatocellular carcinoma: Therapeutic effects and molecular mechanisms. Ren J, Li G, Zhao W, Lin L, Ye T. World J Gastroenterol; 2016 Apr 21; 22(15):3962-8. PubMed ID: 27099439 [Abstract] [Full Text] [Related]
2. Norcantharidin enhances ABT-737-induced apoptosis in hepatocellular carcinoma cells by transcriptional repression of Mcl-1. Zhang S, Li G, Ma X, Wang Y, Liu G, Feng L, Zhao Y, Zhang G, Wu Y, Ye X, Qin B, Lu J. Cell Signal; 2012 Sep 21; 24(9):1803-9. PubMed ID: 22609455 [Abstract] [Full Text] [Related]
3. [Inhibitory effect of norcantharidin combined with evodiamine on the growth of human hepatic carcinoma cell line HepG2 in vitro]. Liu Y, Zahng J, You Z, Liao H. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug 21; 30(8):824-8. PubMed ID: 25108435 [Abstract] [Full Text] [Related]
4. The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib. Hikita H, Takehara T, Shimizu S, Kodama T, Shigekawa M, Iwase K, Hosui A, Miyagi T, Tatsumi T, Ishida H, Li W, Kanto T, Hiramatsu N, Hayashi N. Hepatology; 2010 Oct 21; 52(4):1310-21. PubMed ID: 20799354 [Abstract] [Full Text] [Related]
6. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells. Gao Y, Li W, Liu R, Guo Q, Li J, Bao Y, Zheng H, Jiang S, Hua B. Oncol Rep; 2017 Aug 21; 38(2):1224-1232. PubMed ID: 28677802 [Abstract] [Full Text] [Related]
7. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells. Chen YN, Chen JC, Yin SC, Wang GS, Tsauer W, Hsu SF, Hsu SL. Int J Cancer; 2002 Jul 10; 100(2):158-65. PubMed ID: 12115564 [Abstract] [Full Text] [Related]
8. Clitocine induces apoptosis and enhances the lethality of ABT-737 in human colon cancer cells by disrupting the interaction of Mcl-1 and Bak. Sun JG, Xiang J, Zeng XL, Li X, Wu P, Fung KP, Liu FY. Cancer Lett; 2014 Dec 28; 355(2):253-63. PubMed ID: 25304383 [Abstract] [Full Text] [Related]
9. [Molecular mechanism of norcantharidin inducing apoptosis in liver cancer cells]. Li GQ, Zhang SJ, Lü JF, Wu Y, Li J, Zhang G, Yu JT. Zhonghua Yi Xue Za Zhi; 2010 Aug 10; 90(30):2145-8. PubMed ID: 21029633 [Abstract] [Full Text] [Related]
11. Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo. Liu MC, Liu L, Wang XR, Shuai WP, Hu Y, Han M, Gao JQ. Int J Nanomedicine; 2016 Aug 10; 11():1395-412. PubMed ID: 27110110 [Abstract] [Full Text] [Related]
12. Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis. Simonin K, N'Diaye M, Lheureux S, Loussouarn C, Dutoit S, Briand M, Giffard F, Brotin E, Blanc-Fournier C, Poulain L. Apoptosis; 2013 Apr 10; 18(4):492-508. PubMed ID: 23344663 [Abstract] [Full Text] [Related]
13. Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells. Ruvolo PP, Ruvolo VR, Benton CB, AlRawi A, Burks JK, Schober W, Rolke J, Tidmarsh G, Hail N, Davis RE, Andreeff M. Biochim Biophys Acta; 2016 Apr 10; 1863(4):562-71. PubMed ID: 26704388 [Abstract] [Full Text] [Related]
14. Glycycoumarin Sensitizes Liver Cancer Cells to ABT-737 by Targeting De Novo Lipogenesis and TOPK-Survivin Axis. Zhang E, Yin S, Lu X, Ye L, Fan L, Hu H. Nutrients; 2018 Mar 15; 10(3):. PubMed ID: 29543705 [Abstract] [Full Text] [Related]
15. FAM46C is critical for the anti-proliferation and pro-apoptotic effects of norcantharidin in hepatocellular carcinoma cells. Zhang QY, Yue XQ, Jiang YP, Han T, Xin HL. Sci Rep; 2017 Mar 24; 7(1):396. PubMed ID: 28341836 [Abstract] [Full Text] [Related]
20. PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-xL-targeting strategies, provided that Bim expression is induced. Jebahi A, Villedieu M, Pétigny-Lechartier C, Brotin E, Louis MH, Abeilard E, Giffard F, Guercio M, Briand M, Gauduchon P, Lheureux S, Poulain L. Cancer Lett; 2014 Jun 28; 348(1-2):38-49. PubMed ID: 24650799 [Abstract] [Full Text] [Related] Page: [Next] [New Search]